DEA Balks at Latest Kratom FOIA, refuses to provide further information

2016-11-26T1638180000.jpg

On August 30th, 2016, the DEA filed a notice of intent to temporarily designate Kratom (specifically its alkaloids mitragynine and 7-hydroxymitragynine) as a schedule 1 drug. That notice listed 33 footnotes/references, but the actual references themselves were not included in the document itself.

Read More

Image courtesy of: anthonyroberts